Conference Coverage

Most data reassure regarding TNF inhibitors and cancer

Publish date: October 8, 2013

 

EXPERT ANALYSIS FROM PERSPECTIVES IN RHEUMATIC DISEASES 2013

Dr. McInnes disclosed that he has been a speaker, adviser, and/or investigator for Janssen, Roche, Pfizer, BMS, and Novartis. The meeting was held by Global Academy for Medical Education. GAME and this news organization are owned by Frontline Medical Communications.

Pages

Recommended Reading

Combo of smoking while overweight boosts RA incidence
MDedge Rheumatology
Tofacitinib rapidly improves RA signs and symptoms
MDedge Rheumatology
Omega-3 fatty acid found in fish may reduce RA risk
MDedge Rheumatology
Biosimilar matches up well against infliximab in RA trial
MDedge Rheumatology
Patient global score predicts postbiological quality of life gain in RA
MDedge Rheumatology
NSAIDs, methotrexate used most for rheumatoid arthritis
MDedge Rheumatology
Study sheds light on exacerbation risks with RA lung disease
MDedge Rheumatology
RA disease activity assessed differently by patients, physicians, and ultrasound
MDedge Rheumatology
Palmar-plantar psoriasis? Anti-TNF therapy may be culprit
MDedge Rheumatology
Data provide guidance on herpes zoster vaccination in rheumatoid arthritis
MDedge Rheumatology